These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9652614)

  • 1. Lung as reservoir for antidepressants in pharmacokinetic drug interactions.
    Suhara T; Sudo Y; Yoshida K; Okubo Y; Fukuda H; Obata T; Yoshikawa K; Suzuki K; Sasaki Y
    Lancet; 1998 Jan; 351(9099):332-5. PubMed ID: 9652614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine.
    Takano A; Suhara T; Sudo Y; Inoue M; Hashimoto K; Zhang MR; Ichimiya T; Yasuno F; Suzuki K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1289-97. PubMed ID: 12271409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
    Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
    Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.
    Daniel WA; Wójcikowski J
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):115-24. PubMed ID: 10406926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between sertraline and tricyclic antidepressants.
    Lydiard RB; Anton RF; Cunningham T
    Am J Psychiatry; 1993 Jul; 150(7):1125-6. PubMed ID: 8317590
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
    Ashford JJ
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report.
    Haffen E; Vandel P; Bonin B; Vandel S
    Therapie; 1999; 54(6):768-70. PubMed ID: 10709456
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A; Wójcikowski J; Daniel WA
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Feb; 82(2):92-101. PubMed ID: 18219438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
    Moreau X; Jeanningros R; Mazzola-Pomietto P
    Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic antidepressant plasma levels after fluoxetine addition.
    Vandel S; Bertschy G; Bonin B; Nezelof S; François TH; Vandel B; Sechter D; Bizouard P
    Neuropsychobiology; 1992; 25(4):202-7. PubMed ID: 1454161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are gender differences important for the clinical effects of antidepressants?
    Hildebrandt MG; Steyerberg EW; Stage KB; Passchier J; Kragh-Soerensen P;
    Am J Psychiatry; 2003 Sep; 160(9):1643-50. PubMed ID: 12944340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
    Daniel WA; Wójcikowski J
    Pharmacol Toxicol; 1997 Feb; 80(2):62-8. PubMed ID: 9060036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.
    Takano A; Nag S; Gulyás B; Halldin C; Farde L
    Psychopharmacology (Berl); 2011 Jul; 216(2):279-86. PubMed ID: 21336575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
    Kurtz DL; Bergstrom RF; Goldberg MJ; Cerimele BJ
    Clin Pharmacol Ther; 1997 Aug; 62(2):145-56. PubMed ID: 9284850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antidepressants on striatal and accumbens extracellular dopamine levels.
    Ichikawa J; Meltzer HY
    Eur J Pharmacol; 1995 Aug; 281(3):255-61. PubMed ID: 8521908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Veterinary drug profile. Clomipramine (Clomicalm)].
    Pellicaan CH; Knol BW; de Ligt R
    Tijdschr Diergeneeskd; 1999 May; 124(10):313-5. PubMed ID: 10360274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.